Hepatitis C surveillance has been restricted owing to the lack of a sensiti
ve antibody assay for saliva. The aim of our study was to develop and evalu
ate a screening assay for hepatitis C antibody in saliva specimens. Serum/s
aliva pairs were collected from 115 hepatitis C-positive patients. A modifi
ed hepatitis C antibody assay for saliva was developed and linked to testin
g carried out in the diagnostic laboratory. Correlation between the presenc
e of antibody in serum and in saliva was poor (100% vs 85%). However, of 98
patients who were saliva antibody positive, 96 (98%) were also serum hepat
itis C RNA positive and two (2%) were serum hepatitis C RNA negative. Hence
, the correlation between a positive salivary antibody test and the serum h
epatitis C RNA status of intravenous drug users suggests that this test cou
ld be used as a surrogate marker for hepatitis C viraemia in epidemiologica
l studies.